Home > Healthcare > Tissue Diagnostics Market > Table of Contents

Tissue Diagnostics Market Size - By Product (Consumables, Instruments), Technology (Immunohistochemistry (IHC), In-situ Hybridization (ISH), Special Staining, Digital Pathology, Management), Application (Breast Cancer, Prostate Cancer, Lung Cancer, Lymphoma, Gastric Cancer), End-use (Hospitals, Research Laboratories, Pharmaceutical Companies, CROs) – Global Forecast to 2032

  • Report ID: GMI3754
  • Published Date: Jun 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.2    Market scope & definitions

1.3    Base estimates and calculations

1.3.1    North America

1.3.2    Europe

1.3.3    Asia Pacific

1.3.4    Latin America

1.3.5    MEA

1.4    Forecast calculations

1.5    Data validation

1.6    COVID-19 impact analysis at global level

1.7    Data sources

1.7.1    Secondary

1.7.1.1   Paid sources

1.7.1.2   Unpaid sources

1.7.2    Primary

Chapter 2   Executive Summary

2.1    Tissue diagnostics industry 3600 synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Regional trends

2.1.3    Product trends

2.1.4    Technology trends

2.1.5    Application trends

2.1.6    End-use trends

Chapter 3   Tissue Diagnostics Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Rising prevalence of cancer globally

3.2.1.2   Growth of personalized therapeutics and diagnostics

3.2.1.3   Growing demand for digital pathology

3.2.1.4   Increasing number of private diagnostic centers globally

3.2.2    Industry pitfalls & challenges

3.2.2.1   Lack of skilled professionals

3.2.2.2   High cost of diagnosis and reimbursement issues

3.3    Growth potential analysis

3.3.1    By product

3.3.2    By technology

3.3.3    By application

3.3.4    By end-use

3.4    COVID- 19 impact analysis

3.5    Regulatory landscape

3.5.1    U.S.

3.5.2    Europe

3.6    Technology landscape

3.7    Porter's analysis

3.8    PESTEL analysis

Chapter 4   Competitive landscape

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Competitive dashboard

4.4    Company market share, 2022

4.5    Competitive analysis of major market players

4.6    Competitive positioning matrix

4.7    Strategic outlook matrix

Chapter 5   Tissue Diagnostics Market and Forecast, By Product (USD Million)

5.1    Key trends, by product

5.2    Consumables

5.2.1    Kits

5.2.2    Reagents

5.2.3    Antibodies

5.2.4    Probes

5.3    Instruments

5.3.1    Scanners

5.3.2    Tissue Processing Systems

5.3.3    Slide staining systems

5.3.4    Others

Chapter 6   Tissue Diagnostics Market and Forecast, By Technology (USD Million)

6.1    Key trends, by technology

6.2    Immunohistochemistry (IHC)

6.3    In-situ hybridization (ISH)

6.4    Special staining

6.5    Digital pathology

6.6    Management

Chapter 7   Tissue Diagnostics Market Size and Forecast, By Application (USD Million)

7.1    Key trends, by application

7.2    Breast cancer

7.3    Prostate cancer

7.4    Lung cancer

7.5    Lymphoma

7.6    Gastric cancer

7.7    Others

Chapter 8   Tissue Diagnostics Market Size and Forecast, By End-use (USD Million)

8.1    Key trends, by end-use

8.2    Hospitals

8.3    Research laboratories

8.4    Pharmaceutical companies

8.5    CROs

8.6    Others

Chapter 9   Tissue diagnostics Market and Forecast, By Region (USD Million)

9.1    Key regional trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Poland

9.3.7    Switzerland

9.3.8    Norway

9.3.9    Finland

9.3.10    Sweden

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Taiwan

9.4.7    Indonesia

9.4.8    Vietnam

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Colombia

9.5.5    Chile

9.6    Middle East & Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

9.6.4    Israel

Chapter 10   Company Profiles

10.1    F. Hoffmann-La Roche Ltd.

10.2    Abbott Laboratories

10.3    Siemens

10.4    Danaher

10.5    bioMérieux SA

10.6    QIAGEN

10.7    Becton Dickinson & Company

10.8    Merck KGaA

10.9    Thermo Fisher Scientific, Inc.

10.10    Agilent Technologies, Inc

10.11    GE Healthcare

10.12    BioGenex

10.13    Cell Signaling Technology, Inc.

   

Authors: Mariam Faizullabhoy , Subodh Kharad

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 490
  • Countries covered: 31
  • Pages: 210
 Download Free Sample
We use cookies to enhance user experience. (Privacy Policy) X